Unpopular diabetes plan

Collier, Roger
September 2010
CMAJ: Canadian Medical Association Journal;9/7/2010, Vol. 182 Issue 12, pE578
Academic Journal
The article reports on the decision by the Australian government to create a 16-member advisory group that will help in forming its 450 million-Australian-dollar plan to reform diabetes care, following claims of critics that the program will limit options to patients and eliminate them from medicare.


Related Articles

  • Reforms will fragment diabetes care. Moberly, Tom // GP: General Practitioner;2/25/2011, p17 

    The article presents information on the proposed structural reform related to clarity within the Health Bill in Great Britain. It mentions that the National Health Service reform may lead to duplication of work for clinicians could undermine the integration of services across primary and...

  • Novo Nordisk A/S SWOT Analysis.  // Novo Nordisk A/S SWOT Analysis;Oct2013, p1 

    A business analysis of Novo Nordisk A/S, a provider of diabetes products, is presented, focusing on its strengths, weaknesses, opportunities and threats (SWOT) faced. Strengths include leaderhip position in the global diabetes market. Opportunities for improvement include growing global diabetes...

  • Improving Diabetes Care: The Model for Health Care Reform. Kahn, Richard; Anderson, John E. // Diabetes Care;Jun2009, Vol. 32 Issue 6, p1115 

    The article discusses the improvement of the medical management of diabetes as a case study for health care reform in the U.S. In the authors' opinion, diabetes care tends to serve as an epitome of all the challenges being faced by the country. It emphasizes the advantages of health care reform...

  • Diabetes within the NHS in England following implementation of the Health and Social Care Act 2012. Valabhji, Jonathan // Diabetes & Primary Care;2013, Vol. 15 Issue 6, p284 

    The author comments on the replacement of the disease specific improvement body National Health Service (NHS) Diabetes by the NHS Improving Quality in England. He is critical on the provision of high-quality care for diabetes and empowerment of individuals to self-manage their disease. He cites...

  • A Practical Guide to Understanding the New Diabetic Insert Requirements. Wagner, Barry // Podiatry Management;Jun2005, Vol. 24 Issue 5, p77 

    Explains the changes made to the diabetic insert codes, reimbursement and policies in the U.S. Medicare Therapeutic Footwear Program. Reasons for the implementation of the revisions; Utilization issues facing dispensing podiatrists; System for determining Medicare coverage and required...

  • Primary care reform improving diabetes outcomes.  // CMAJ: Canadian Medical Association Journal;12/13/2011 Supplement, p1 

    The article focuses on the potential of new models of primary care based on a collaborative approach in improving outcomes in diabetes care as presented in an analysis of the care provided in Alberta's Primary Care Networks (PCN). Findings of the analyses were presented during the professional...

  • Offering integrated care for HIV/AIDS, diabetes and hypertension within chronic disease clinics in Cambodia. Janssens, B.; Van Damme, W.; Raleigh, B.; Gupta, J.; Khem, S.; Ty, K. Soy; Vun, M. C.; Ford, N.; Zachariah, R. // Bulletin of the World Health Organization;Nov2007, Vol. 85 Issue 11, p880 

    Problem In Cambodia, care for people with HIV/AIDS (prevalence 1.9%) is expanding, but care for people with type II diabetes (prevalence 5-10%), arterial hypertension and other treatable chronic diseases remains very limited. Approach We describe the experience and outcomes of offering...

  • Is the 'scandal' of diabetes care in general practice fact or fiction? Pereira Gray, Denis; Langley, Peter; White, Eleanor; Evans, Philip // British Journal of General Practice;Jun2014, Vol. 64 Issue 623, p300 

    The article offers the author's opinion on the inadequate standards of diabetes care in general practice in Great Britain. The author is critical on the standards promoted by the Department of Health and Diabetes UK. He emphasizes that these standards should be based on good research, and meet...

  • Novo Nordisk A/S SWOT Analysis.  // Novo Nordisk A/S SWOT Analysis;Oct2012, p1 

    A business analysis of Novo Nordisk A/S, a global provider of diabetes products, is provided, focusing on strengths, weaknesses, opportunities and threats (SWOT) faced by the company. Strengths include limited exposure to generic competition and increased focus on North America. Opportunities...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics